Risk of cholecystitis in patients with cancer: A population-based cohort study in Denmark

Cancer

Volumn 113, Issue 12, 2008, Pages 3410-3419

  Thomsen, Reimar W ^a   Thomsen, Henrik F ^a   Nørgaard, Mette ^a   Cetin, Karynsa ^b   McLaughlin, Joseph K ^c,d   Tarone, Robert E ^c,d   Fryzek, Jon P ^b   Sørensen, Henrik T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AMGEN INC   (United States)

^c INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Cancer; Cholecystitis; Cohort study; Risk

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CHOLECYSTITIS; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; DENMARK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PANCREAS CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID CANCER;

AGED; CHOLECYSTITIS; COHORT STUDIES; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POPULATION GROUPS; RISK ASSESSMENT;

EID: 57649131154     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23961     Document Type: Article

References (38)

1. Indar AA, Beckingham IJ. Acute cholecystitis. BMJ. 2002;325:639-643.
2. Glasgow RE, Cho M, Hutter MM, Mulvihill SJ. The spectrum and cost of complicated gallstone disease in California. Arch Surg. 2000;135:1021-1025.
3. Sanders G, Kingsnorth AN. Gallstones. BMJ. 2007;335:295-299.
4. Jensen KH, Jorgensen T. Incidence of gallstones in a Danish population. Gastroenterology. 1991;100:790-794.
5. Shaffer EA. Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20:981-996.
6. Kalliafas S, Ziegler DW, Flancbaum L, Choban PS. Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. Am Surg. 1998;64:471-475.
7. Carr BI. Tumors of the liver and Biliary Tree. In: Fauci AS, Braunwald E, Kasper DL, et al. Harrison's Principles of Internal Medicine, 17th ed. Available at: http://www.accessmedicine.com/content.aspx?aID=2885016.
8. Rolston KV, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis. 2007;45:228-233.
9. Gonzalez-Perez A, Garcia Rodriguez LA. Gallbladder disease in the general population: association with cardiovascular morbidity and therapy. Pharmacoepidemiol Drug Saf. 2007;16:524-531.
10. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287:2398-2399.
11. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull. 1997;44:535-539.
12. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
13. Lassen A, Hallas J, de Muckadell OBS. Complicated and uncomplicated peptic ulcers in a Danish County 1993-2002: a population-based cohort study. Am J Gastroenterol. 2006;101:945-953.
14. Nickelsen TN. Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger. 2001;164:33-37.
15. Jensen AR, Overgaard J, Storm HH. Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from 1 county in Denmark. Eur J Cancer Prev. 2002;11:359-364.
16. Mahnke D, Chen YK, Antillon MR, Brown WR, Mattison R, Shah RJ. A prospective study of complications of endoscopic retrograde cholangiopancreatography and endoscopic ultrasound in an ambulatory endoscopy center. Clin Gastroenterol Hepatol. 2006;4:924-930.
17. Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastrointest Endosc. 2004;60:721-731.
18. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909-919.
19. Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001;96:417-423.
20. Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc. 2002;56:652-656.
21. Ong TZ, Khor JL, Selamat DS, Yeoh KG, Ho KY. Complications of endoscopic retrograde cholangiography in the post-MRCP era: a tertiary center experience. World J Gastroenterol. 2005;11:5209-5212.
22. Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729-734.
23. Isayama H, Kawabe T, Nakai Y, et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol. 2006;4:1148-1153.
24. Suk KT, Kim HS, Kim JW, et al. Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction. Gastrointest Endosc. 2006;64:522-529.
25. Buyukasik Y, Kosar A, Demiroglu H, Altnok G, Ozcebe OI, Dundar S. Acalculous acute cholecystitis in leukemia. J Clin Gastroenterol. 1998;27:146-148.
26. Gorschluter M, Marklein G, Hofling K, et al. Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology. Br J Haematol. 2002;117:351-358.
27. Gorschluter M, Mey U, Strehl J, et al. Cholecystitis in neutropenic patients: retrospective study and systematic review. Leuk Res. 2006;30:521-528.
28. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86:s836-s842.
29. Chang SC, Rashid A, Gao YT, et al. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. Carcinogenesis. 2008;29:944-948.
30. Stolzenberg-Solomon RZ, Adams K, Leitzmann M, et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol. 2008;167:586-597.
31. Hsing AW, Sakoda LC, Chua S Jr. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007;86:s843-s857.
32. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men. Gut. 2005;54:823-828.
33. Randi G, Ferraroni M, Talamini R, et al. Glycemic index, glycemic load and thyroid cancer risk. Ann Oncol. 2008;19:380-383.
34. Chetty R, Clark SP. Cholecystitis, cholelithiasis, and ganglioneuromatosis of the gall bladder: an unusual presentation of MEN type 2b. J Clin Pathol. 1993;46:1061-1063.
35. Lee HK, Han HS, Min SK, Lee JH. Sex-based analysis of the outcome of laparoscopic cholecystectomy for acute cholecystitis. Br J Surg. 2005;92:463-466.
36. Merriam LT, Kanaan SA, Dawes LG, et al. Gangrenous cholecystitis: analysis of risk factors and experience with laparoscopic cholecystectomy. Surgery. 1999;126:680-685.
37. Giger UF, Michel JM, Opitz I, Inderbitzin DT, Kocher T, Krahenbuhl L. Risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy: analysis of 22,953 consecutive cases from the Swiss Association of Laparoscopic and Thoracoscopic Surgery Database. J Am Coll Surg. 2006;203:723-728.
38. Lee CC, Chang IJ, Lai YC, Chen SY, Chen SC. Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis. Am J Gastroenterol. 2007;102:563-569.